Janssen’s Newly Approved Ponvory Joins Crowded MS Space

FDA Approved
Ponvory is the fourth S1P modulator approved to treat MS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip